GO
Loading...

Health Care Equipment and Supplies

More

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

  • March 27- Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients. The FDA asked for a new trial of the drug-device combination, but Alimera's partner, Psivida Corp, said that additional trials were not necessary.

  • March 14- Shares of healthcare information provider Castlight Health Inc rose more than 160 percent in their debut, making the listing the strongest by a technology company so far this year. Castlight's shares opened at $37.50 and touched a high of $41.95 on the New York Stock Exchange, valuing the company at about $3.63 billion.

  • March 14- Medical device maker Hologic Inc appointed a former Johnson& Johnson executive as chief operating officer, three months after naming a new chief executive as part of a deal with activist investor Carl Icahn.

  • Venture funds see growth in health care start-ups Sunday, 9 Mar 2014 | 1:17 PM ET

    As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.

  • March 7- U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares as its private equity owners look to cash out. The company, which was taken private for $11.4 billion in 2007, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering.

  • Biomet files for IPO to raise up to $100 mln Friday, 7 Mar 2014 | 6:48 AM ET

    March 7- U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares. The company, which was taken private for $11.4 billion in 2007 by a private equity consortium, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering.

  • Smile! Here's the next 'smart' product Thursday, 20 Feb 2014 | 10:00 AM ET

    P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.

  • Obamacare Inc: Allies urge White House to tap CEO Monday, 30 Dec 2013 | 7:28 AM ET

    The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.

  • Icahn reports large stake in medical device maker Thursday, 21 Nov 2013 | 10:25 AM ET
    Carl Icahn, billionaire investor and chairman of Icahn Enterprises Holdings LP

    Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover

  • One man, one small business, four billionaires Wednesday, 13 Nov 2013 | 8:00 AM ET

    An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."

  • JNJ to pay $2.2 billion in US probe: Feds Monday, 4 Nov 2013 | 1:53 PM ET

    Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.

  • Prognosis: Healthy earnings for pharma, biotech Tuesday, 16 Jul 2013 | 5:46 PM ET
    A doctor checks a patient who is experiencing flu symptoms.

    Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.

  • Heart Device Approval Delays Leave Doctors Frustrated Monday, 27 May 2013 | 11:33 AM ET

    Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.

  • Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.

  • Patients Scarred After Robotic Surgery Friday, 19 Apr 2013 | 8:58 AM ET
    Da Vinci Surgical robot designed to facilitate complex surgery using a minimally invasive approach.

    Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.

  • Marketing Is Key to Surgical Robot’s Success Thursday, 18 Apr 2013 | 8:14 PM ET

    If the critics of robotic surgery are right—that safety is an issue—how is that it was performed on 450,000 people last year? The answer may lie in one word: Marketing.

  • Counting the Problems of Robot-Assisted Surgery Thursday, 18 Apr 2013 | 7:58 PM ET
    Dr. Marty Makary of Johns Hopkins University Hospital

    The number of complications from robot-assisted surgery using Intuitive Surgical's da Vinci robot are underreported, allege critics of the procedure, fanning the controversy around the company's pioneering product.